Folgen
Hezekiah Alkali Isa
Hezekiah Alkali Isa
University of Abuja and University of Abuja Teaching Hospital
Bestätigte E-Mail-Adresse bei uniabuja.edu.ng
Titel
Zitiert von
Zitiert von
Jahr
Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis
BOP Musa, GC Onyemelukwe, JO Hambolu, AI Mamman, AH Isa
Clinical and Vaccine Immunology 17 (4), 602-608, 2010
922010
HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges
Blood Cells, Molecules and Diseases 78, 22-28, 2019
532019
Pattern of primary tumours and tumour-like lesion of bone in Zaria, Northern Nigeria: A review of 127 cases
HAI A. Mohammed
West African Journal of Medicine 26 (1), 37-41, 2007
502007
Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study
FBP Obiageli E Nnodu, Alayo Sopekan, Uche Nnebe-Agumadu, Chinatu Ohiaeri ...
Lancet Haematology 7, e534-540, 2020
442020
Primary bone tumours and tumour-like lesions in children in Zaria, Nigeria
AAOE Abdullahi Mohammed, Malami A. Sani , Isah A. Hezekiah
African Journal of Paediatric Surger 17 (1), 16-18, 2010
29*2010
Preliminary Evaluation of a Point-of-Care Testing Device (SickleSCAN™) in Screening for Sickle Cell Disease
Hemoglobin, 2017
262017
Barriers to therapeutic use of hydroxyurea for sickle cell disease in Nigeria: a cross-sectional survey
EC Okocha, J Gyamfi, N Ryan, O Babalola, EA Etuk, R Chianumba, ...
Frontiers in genetics 12, 765958, 2022
202022
Sickle cell disease clinical phenotypes in Nigeria: A preliminary analysis of the Sickle Pan Africa Research Consortium Nigeria data base
Blood Cells, Molecules and Diseases 84, 2020
202020
The incidence of HIV among blood donors in Kaduna, Nigeria
A Hassan, AI Mamman, AJ Ahmed, AH Isa, AA Babadoko
African Health Sciences 8 (1), 60-60, 2008
202008
The pattern of distribution of ABO blood groups in North Western Nigeria
SAM Hassan A, Babadoko AA, Ahmed AJ, Isa AH
Annals of Nigerian Medicine 1 (2), 17-18, 2005
202005
Reference ranges of some haematological parameters in healthy northern Nigerian adults
AH Isa, A Hassan, Y Garba, IP Ijei
Jos Journal of Medicine 6 (3), 10-15, 2012
182012
Prevalence and clinical manifestation of lymphomas in North Eastern Nigeria
AJP Mava Yakubu, Baba U Ahmadu , Timothy S Yerima , Pius Simon , Isa A Hezekiah
Indian Journal of Cancer 52 (4), 551-555, 2015
142015
A Multi-centre Survey of Acceptability of Newborn Screening for Sickle Cell Disease in Nigeria
Cureus 10 (3), e2354, 2018
112018
Hereditary spherocytosis in a 27-year-old woman: case report
A Hassan, AA Babadoko, AH Isa, P Abunimye
Annals of African Medicine 8 (1), 61-63, 2009
112009
Seroprevalence of hepatitis C virus antibodies amongst blood donors in Ahmadu Bello University Teaching Hospital (ABUTH) Kaduna
AH Isa, A Hassan, A Mamman, AA Bababdoko, HM Muktar, AJ Ahmed
African Journal of Clinical and Experimental Microbiology 11 (2), 2010
92010
Development of multi-level standards of care recommendations for sickle cell disease: Experience from SickleInAfrica
V Paintsil, M Ally, H Isa, KA Anie, J Mgaya, M Nkanyemka, V Nembaware, ...
Frontiers in Genetics 13, 1052179, 2023
82023
Strategies to improve healthcare services for patients with sickle cell disease in Nigeria: The perspectives of stakeholders
H Isa, E Okocha, SA Adegoke, U Nnebe-Agumadu, A Kuliya-Gwarzo, ...
Frontiers in Genetics 14, 1052444, 2023
72023
Outcome of Hydroxyurea use in SCD and evaluation of patients’ perception and experience in Nigeria
RI Chianumba, AOD Ofakunrin, J Morrice, O Olanrewaju, O Oniyangi, ...
Frontiers in Genetics 13, 826132, 2022
72022
Using dried blood spot on HemoTypeSC™, a new frontier for newborn screening for sickle cell disease in Nigeria
CO Okeke, RI Chianumba, H Isa, S Asala, OE Nnodu
Frontiers in Genetics 13, 1013858, 2022
62022
Utilization of Pneumococcal Vaccine and Penicillin Prophylaxis in Sickle Cell Disease in Three African Countries: Assessment among Healthcare Providers in SickleInAfrica
Hemoglobin, 2021
62021
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20